Arrakis Therapeutics

Arrakis

Waltham, United States · Founded 2015 · $113.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$113.0M
Last Round
Series CNov 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Arrakis Therapeutics is pioneering a new class of medicines it calls RNA-targeted small molecules (rSMs), discovering small-molecule drug compounds that act directly on RNA. The company has a simple but powerful vision: to extend small-molecule medicines into new realms of RNA biology and unlock that biology for patients. Arrakis says its platform will allow it to reach hundreds of biological targets not currently accessible or untapped by genetic medicine, opening a new path for discovering RNA-targeted oral medicines. Its destination is powerful new therapies for patients everywhere.

Summary

Arrakis Therapeutics is a Biotech company based in Waltham, United States, founded in 2015. It has raised $113.0M in total across 3 rounds, most recently a Series C round in Nov 2020. Investors include Nextech Invest, venBIO Partners and Canaan Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CNov 2020

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arrakis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/arrakis-therapeutics"><img src="https://indexed.vc/api/badge/company/arrakis-therapeutics" alt="Arrakis Therapeutics on Indexed.vc" width="260" height="76" /></a>